Athanasios Papathanasiou
Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study
Papathanasiou, Athanasios; Hibbert, Aimee; Tallantyre, Emma; Harding, Katharine; Selvam, Adithya Panneer; Morgan, Matthew; Quainton, Charlotte; Talaei, Maryam; Arun, Tarunya; Ingram, Gillian; Law, Graham R.; Evangelou, Nikos
Authors
Aimee Hibbert
Emma Tallantyre
Katharine Harding
Adithya Panneer Selvam
Matthew Morgan
Charlotte Quainton
Maryam Talaei
Tarunya Arun
Gillian Ingram
Graham R. Law
NIKOS EVANGELOU Nikos.Evangelou@nottingham.ac.uk
Clinical Professor
Abstract
Background: Annualized relapse rate (ARR) is used as an outcome measure in multiple sclerosis (MS) clinical trials. Previous studies demonstrated that ARR has reduced in placebo groups between 1990 and 2012. This study aimed to estimate real-world ARRs from contemporary MS clinics in the UK, in order to improve the feasibility estimations for clinical trials and facilitate MS service planning. Methods: A multicentre observational, retrospective study of patients with MS from 5 tertiary neuroscience centres in the UK. We included all adult patients with a diagnosis of MS that had a relapse between 01/04/2020 and 30/06/2020. Results: One hundred thirteen out of 8783 patients had a relapse during the 3-month study period. Seventy-nine percent of the patients with a relapse were female, the mean age was 39 years, and the median disease duration was 4.5 years; 36% of the patients that had a relapse were on disease-modifying treatment. The ARR from all study sites was estimated at 0.05. The ARR for relapsing remitting MS (RRMS) was estimated at 0.08, while the ARR for secondary progressive MS (SPMS) was 0.01. Conclusions: We report a lower ARR compared to previously reported rates in MS.
Journal Article Type | Article |
---|---|
Acceptance Date | May 2, 2023 |
Online Publication Date | May 20, 2023 |
Publication Date | 2023-10 |
Deposit Date | May 25, 2023 |
Publicly Available Date | May 21, 2024 |
Journal | Neurological Sciences |
Print ISSN | 1590-1874 |
Electronic ISSN | 1590-3478 |
Publisher | Springer Science and Business Media LLC |
Peer Reviewed | Peer Reviewed |
Volume | 44 |
Issue | 10 |
Pages | 3629-3635 |
DOI | https://doi.org/10.1007/s10072-023-06838-1 |
Keywords | Multiple sclerosis, Relapse, Rrms, Spms, Annualized Relapse Rate (Arr) |
Public URL | https://nottingham-repository.worktribe.com/output/21107773 |
Publisher URL | https://link.springer.com/article/10.1007/s10072-023-06838-1 |
PMID | 37208584 |
Files
Real world annualized relapse rates
(342 Kb)
PDF
You might also like
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis
(2022)
Journal Article
Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis
(2022)
Journal Article
Decentralised clinical trials in multiple sclerosis research
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search